Literature DB >> 1642278

Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.

R K Tripathi1, K M Strunk, L B Giebel, R G Weleber, R A Spritz.   

Abstract

Type I (tyrosinase-deficient) oculocutaneous albinism (OCA) results from mutations of the gene encoding tyrosinase, the enzyme that catalyzes the first 2 steps of melanin pigment biosynthesis. In type IA (tyrosinase-negative) OCA tyrosinase enzymatic activity is completely absent, and in type IB ("yellow") OCA tyrosinase activity is greatly reduced. Here, we describe 11 novel mutations of the tyrosinase gene in Caucasian patients with these 2 forms of type I OCA. Type I OCA in Caucasians appears to result from a great variety of different uncommon alleles. More than 80% of the known missense substitutions associated with type I OCA cluster within 2 relatively small regions of the tyrosinase polypeptide, suggesting that these may correspond to functionally important sites within the enzyme.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642278     DOI: 10.1002/ajmg.1320430523

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

1.  Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.

Authors:  R Halaban; S Svedine; E Cheng; Y Smicun; R Aron; D N Hebert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

3.  Nitisinone improves eye and skin pigmentation defects in a mouse model of oculocutaneous albinism.

Authors:  Ighovie F Onojafe; David R Adams; Dimitre R Simeonov; Jun Zhang; Chi-Chao Chan; Isa M Bernardini; Yuri V Sergeev; Monika B Dolinska; Ramakrishna P Alur; Murray H Brilliant; William A Gahl; Brian P Brooks
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

4.  Molecular analysis of Korean patients with oculocutaneous albinism.

Authors:  Shin Hae Park; Hyojin Chae; Yonggoo Kim; Myungshin Kim
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

5.  Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.

Authors:  Monika B Dolinska; Nicole J Kus; S Katie Farney; Paul T Wingfield; Brian P Brooks; Yuri V Sergeev
Journal:  Pigment Cell Melanoma Res       Date:  2017-01       Impact factor: 4.693

6.  Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel.

Authors:  R Gershoni-Baruch; A Rosenmann; S Droetto; S Holmes; R K Tripathi; R A Spritz
Journal:  Am J Hum Genet       Date:  1994-04       Impact factor: 11.025

7.  Direct fluorescence analysis of genetic polymorphisms by hybridization with oligonucleotide arrays on glass supports.

Authors:  Z Guo; R A Guilfoyle; A J Thiel; R Wang; L M Smith
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

8.  Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).

Authors:  R K Tripathi; S Bundey; M A Musarella; S Droetto; K M Strunk; S A Holmes; R A Spritz
Journal:  Am J Hum Genet       Date:  1993-12       Impact factor: 11.025

9.  Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population.

Authors:  Thomas J Jaworek; Tasleem Kausar; Shannon M Bell; Nabeela Tariq; Muhammad Imran Maqsood; Asma Sohail; Muhmmmad Ali; Furhan Iqbal; Shafqat Rasool; Saima Riazuddin; Rehan S Shaikh; Zubair M Ahmed
Journal:  Orphanet J Rare Dis       Date:  2012-06-26       Impact factor: 4.123

10.  Versatile and efficient in vivo genome editing with compact Streptococcus pasteurianus Cas9.

Authors:  Zhiquan Liu; Siyu Chen; Wanhua Xie; Yuning Song; Jinze Li; Liangxue Lai; Zhanjun Li
Journal:  Mol Ther       Date:  2021-06-24       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.